Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04308694 · ClinicalTrials.gov registry record · Early Phase 1
Opioid Treatment Program (OTP)-Pharmacy Collaboration for Methadone Maintenance Treatment
A Early Phase 1 study of Opioid Use Disorder, sponsored by Friends Research Institute.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 20
- Enrollment target
- 3
- Study locations
NCT04308694 is a Early Phase 1 study of Opioid Use Disorder that has completed, run by Friends Research Institute. The registered enrollment target is 20 participants, below the 4,656-participant average among 257 other Opioid Use Disorder trials with a reported enrollment target (100% lower). The trial reports 3 study locations across 1 state.
The verdict
NCT04308694, a Early Phase 1 study of Opioid Use Disorder, has completed, sponsored by Friends Research Institute.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 20 participants
- Enrollment target
- 3
- Study locations
Study Summary
The overarching goal of this pilot study is to explore the feasibility, acceptability, and patient/provider satisfaction of pharmacy-based administration and dispensing of methadone for opioid use disorder. The results gained will inform the development of a future multisite randomized clinical trial.
Conditions Studied
Interventions
- DRUG Pharmacy-based methadone administration and dispensing
Study Locations (3)
North Carolina
- Health Park Pharmacy - Raleigh
- Morse Clinic of North Raleigh - Raleigh
- Morse Clinic of Zebulon - Zebulon
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2020-08-06 |
| Est. Completion | 2021-01-18 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04308694
The ClinicalTrials.gov registry entry for NCT04308694 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 4,656-participant average among 257 other Opioid Use Disorder trials with a reported enrollment target (100% lower). The listed sponsor is Friends Research Institute, which has 41 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Opioid Use Disorder appearing as the primary indexed condition, and to 1 intervention - of which Pharmacy-based methadone administration and dispensing is the first listed.
NCT04308694 reports 3 study locations spanning 1 distinct geographic area - top geographies include North Carolina.
Frequently Asked Questions
What is clinical trial NCT04308694 about?
NCT04308694 is a clinical study titled "Opioid Treatment Program (OTP)-Pharmacy Collaboration for Methadone Maintenance Treatment". The overarching goal of this pilot study is to explore the feasibility, acceptability, and patient/provider satisfaction of pharmacy-based administration and dispensing of methadone for opioid use disorder. The results gained will inform the development of a future multisite randomized clinical tria...
What is the current status of trial NCT04308694?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 20 participants. The study started on 2020-08-06. Estimated completion is 2021-01-18.
What conditions does trial NCT04308694 study?
This clinical trial studies the following conditions: Opioid Use Disorder.
What interventions are being tested in trial NCT04308694?
The interventions under investigation include: Pharmacy-based methadone administration and dispensing (DRUG).
Who is sponsoring clinical trial NCT04308694?
This trial is sponsored by Friends Research Institute, which has 41 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04308694 being conducted?
This trial has 3 study locations across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Opioid Use Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Clinical Trial Comparing Buprenorphine Formulations for High Potency Synthetic Opioid Use
RECRUITING · Early Phase 1
-
Cannabidiol in Opioid Use Disorder and Chronic Pain
RECRUITING · Early Phase 1
-
Behavioral Effects of Drugs (Inpatient): 43 (Opioids, Cocaine, n-Acetylcysteine)
RECRUITING · Early Phase 1
-
Open Trial of Technology-Enhanced Behavioral Intervention for Buprenorphine Retention in Pregnant and Postpartum People
ACTIVE NOT RECRUITING · Early Phase 1
-
Enhancing Prospective Thinking in Early Recovery (PARK)
COMPLETED · Early Phase 1
-
Sustaining Recovery for People on Opioid Agonist Treatment With Conversational Agents
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.